Cancer patients looking for clinical trials of oncology therapies in
their own areas plus information and news to help them understand the
disease and its treatments have a valuable new online resource at www.ClinicalResearch.com.
The Quintiles-created site has now been recognized with its third Web
Health Award in as many years.
Cancer microsite within ClinicalResearch.com (Photo: Business Wire)
ClinicalResearch.com is a patient community of more than 230,000
registered users. The site is dedicated to educating patients and the
general public about clinical trials and providing an abundance of
information on therapeutic areas such as cancer, diabetes and
Alzheimer's disease. It features a global database of ongoing clinical
trials searchable by condition and global geography.
This year's Web Health Award is for a cancer
microsite within ClinicalResearch.com. The goal of the cancer
microsite is to empower cancer patients in understanding the role of
molecular-targeted medicine in the treatment of cancer and to
demonstrate how knowledge of an individual's tumor molecular profile can
help both patients and their physicians make better-informed,
data-driven decisions about enrolling in clinical trials.
The Molecular Targeted Cancer Care 101 resource provides cacer patients
with information on individualized medicine and helps inform decisions
regarding enrollment in clinical trials for oncology therapies. It was
developed through a collaboration between Quintiles and N-of-One which
supplies synthesized molecular-based insights for www.ClinicalResearch.com
through its PrecisionWorks™ knowledge integration framework for
personalized cancer medicine.
Health Awards were founded 14 years ago to recognize high-quality
digital health resources for consumers and health professionals. Judging
criteria included content, usability and creativity. Winners were
selected from nearly 600 entries judged by a panel of distinguished
experts in digital health media.
"Quintiles is humbled to receive a third Web Health Award for our
ClinicalResearch.com patient resource," said Jodi Snare, Quintiles vice
president, digital strategy. "As oncology shifts toward individualized
care, patients and physicians must understand complex biological
concepts if they are to understand their tumors and their medical
choices," Snare concluded.
"A growing body of research supports the use of molecular diagnostic
technologies and associated targeted therapies to improve outcomes for
individuals diagnosed with cancer," said Jennifer Levin Carter, MD,
founder and Chief Medical Officer of N-of-One. "We are very pleased to
partner with Quintiles to offer a unique resource that couples
state-of-the-art, molecular insights about precision cancer medicine
with valuable information about cancer clinical trials to empower
patients to understand and discuss with their caregivers the role of
molecular-targeted oncology in their cancer treatment strategy."
ClinicalResearch.com is provided to patients at no cost through
Quintiles' Digital Patient Unit (DPU). The DPU engages patients through
internet-based communities and outreach to participate in clinical
studies, observational research and disease management programs for
biopharma customers. The unit engages an aggregate of nearly 3 million
registered users of ClinicalResearch.com,
and Quintiles' other, proprietary patient communities.
Quintiles is the world's leading provider of biopharmaceutical services.
With a network of more than 27,000 professionals working in more than 80
countries, we have helped develop or commercialize all of the top 50
best selling drugs on the market. With extensive therapeutic, scientific
and analytics expertise, we help biopharmaceutical and health sciences
customers navigate the increasingly complex landscape with more
predictability to enable better outcomes.
to subscribe to Mobile Alerts for Quintiles.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20121218005787/en/
[ Back To NFVZone's Homepage ]